共 50 条
- [21] Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trialLANCET, 2011, 378 (9785): : 41 - 48Aujesky, DrahomirRoy, Pierre-MarieVerschuren, FranckRighini, MarcOsterwalder, JosephEgloff, MichaelRenaud, BertrandVerhamme, PeterStone, Roslyn A.Legal, CatherineSanchez, OlivierPugh, Nathan A.N'gako, AlfredCornuz, JacquesHugii, OlivierBeer, Hans-JuergPerrier, ArnaudFine, Michael J.Yealy, Donald M.
- [22] Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trialLANCET, 2018, 391 (10139): : 2525 - 2536Parekh, Dipen J.Reis, Isildinha M.Castle, Erik P.Gonzalgo, Mark L.Woods, Michael E.Svatek, Robert S.Weizer, Alon Z.Konety, Badrinath R.Tollefson, MathewKrupski, Tracey L.Smith, Norm D.Shabsigh, AhmadBarocas, Daniel A.Quek, Marcus L.Dash, AtreyaKibel, Adam S.Shemanski, LynnPruthi, Raj S.Montgomery, Jeffrey ScottWeight, Christopher J.Sharp, David S.Chang, Sam S.Cookson, Michael S.Gupta, Gopal N.Gorbonos, AlexUchio, Edward M.Skinner, EilaVenkatramani, VivekSoodana-Prakash, NachikethKendrick, KerriSmith, Joseph A., Jr.Thompson, Ian M.
- [23] Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trialLANCET INFECTIOUS DISEASES, 2021, 21 (04): : 559 - 568Bandyopadhyay, Ananda S.Gast, ChrisRivera, LuisSaez-Llorens, XavierOberste, M. StevenWeldon, William C.Modlin, JohnClemens, RalfCosta Clemens, Sue AnnJimeno, JoseRuttimann, Ricardo
- [24] Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialLANCET ONCOLOGY, 2021, 22 (06): : 883 - 892Sacco, Assuntina G.Chen, RuifengWorden, Francis P.Wong, Deborah J. L.Adkins, DouglasSwiecicki, PaulChai-Ho, WanxingOppelt, PeterGhosh, DebanjaliBykowski, JulieMolinolo, AlfredoPittman, EmilyEstrada, M. ValeriaGold, KathrynDaniels, GregoryLippman, Scott M.Natsuhara, AmandaMesser, KarenCohen, Ezra E. W.
- [25] EXtending Omalizumab Treatment Intervals in patients with Chronic spontaneous urticaria (EXOTIC): protocol of a multicentre, randomised, open-label, non-inferiority trialBMJ OPEN, 2025, 15 (01):Zhang, Ditte GeorginaSorensen, Jennifer AstrupGhazanfar, Misbah NoshelaAli, ZarqaVestergaard, ChristianThyssen, JacobEgeberg, AlexanderThomsen, Simon Francis
- [26] Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trialLANCET INFECTIOUS DISEASES, 2012, 12 (05): : 381 - 387Imamura, HiroshiKurokawa, YukinoriTsujinaka, ToshimasaInoue, KentaroKimura, YutakaIijima, ShoheiShimokawa, ToshioFurukawa, Hiroshi
- [27] Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialLANCET ONCOLOGY, 2019, 20 (10): : 1349 - 1359Nichols, Anthony C.Theurer, JuliePrisman, EitanRead, NancyBerthelet, EricTran, EricFung, Kevinde Almeida, John R.Bayley, AndrewGoldstein, David P.Hier, MichaelSultanem, KhalilRichardson, KeithMlynarek, AlexKrishnan, Prof SurenLe, HienYoo, JohnMacNeil, S. DanielleWinquist, EricHammond, J. AlexVenkatesan, VaragurKuruvilla, SaraWarner, AndrewMitchell, SylviaChen, JeffCorsten, MartinJohnson-Obaseki, StephanieEapen, LibniOdell, MichaelParker, ChristinaWehrli, BretKwan, KeithPalma, David A.
- [28] Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trialLANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (01): : 47 - 56Hamaguchi, TetsuyaShimada, YasuhiroMizusawa, JunkiKinugasa, YusukeKanemitsu, YukihideOhue, MasayukiFujii, ShoichiTakiguchi, NobuhiroYatsuoka, ToshimasaTakii, YasumasaOjima, HitoshiMasuko, HiroyukiKubo, YoshiroMishima, HideyukiYamaguchi, TakashiBando, HiroyukiSato, ToshihikoKato, TakeshiNakamura, KenichiFukuda, HaruhikoMoriya, Yoshihiro
- [29] Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trialLANCET ONCOLOGY, 2019, 20 (03): : 352 - 360Wang, Shu-LianFang, HuiSong, Yong-WenWang, Wei-HuHu, ChenLiu, Yue-PingJin, JingLiu, Xin-FanYu, Zi-HaoRen, HuaLi, NingLu, Ning-NingTang, YuTang, YuanQi, Shu-NanSun, Guang-YiPeng, RanLi, ShuaiChen, BoYang, YongLi, Ye-Xiong
- [30] Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialLANCET, 2016, 388 (10054): : 1883 - 1892Zhang, LiHuang, YanHong, ShaodongYang, YunpengYu, GengshengJia, JunPeng, PeijianWu, XuanLin, QingXi, XupingPeng, JiewenXu, MingjunChen, DongpingLu, XiaojunWang, RenshengCao, XiaolongChen, XiaozhongLin, ZhixiongXiong, JianpingLin, QinXie, ConghuaLi, ZhihuaPan, JianjiLi, JingaoWu, ShixiuLian, YingniYang, QuanlieZhao, Chong